Niioka, T.;                     Kagaya, H.;                     Saito, M.;                     Inoue, T.;                     Numakura, K.;                     Habuchi, T.;                     Satoh, S.;                     Miura, M.    
        Capability of Utilizing CYP3A5 Polymorphisms to Predict Therapeutic Dosage of Tacrolimus at Early Stage  Post-Renal Transplantation. Int. J. Mol. Sci. 2015, 16, 1840-1854.
    https://doi.org/10.3390/ijms16011840
    AMA Style
    
                                Niioka T,                                 Kagaya H,                                 Saito M,                                 Inoue T,                                 Numakura K,                                 Habuchi T,                                 Satoh S,                                 Miura M.        
                Capability of Utilizing CYP3A5 Polymorphisms to Predict Therapeutic Dosage of Tacrolimus at Early Stage  Post-Renal Transplantation. International Journal of Molecular Sciences. 2015; 16(1):1840-1854.
        https://doi.org/10.3390/ijms16011840
    
    Chicago/Turabian Style
    
                                Niioka, Takenori,                                 Hideaki Kagaya,                                 Mitsuru Saito,                                 Takamitsu Inoue,                                 Kazuyuki Numakura,                                 Tomonori Habuchi,                                 Shigeru Satoh,                                 and Masatomo Miura.        
                2015. "Capability of Utilizing CYP3A5 Polymorphisms to Predict Therapeutic Dosage of Tacrolimus at Early Stage  Post-Renal Transplantation" International Journal of Molecular Sciences 16, no. 1: 1840-1854.
        https://doi.org/10.3390/ijms16011840
    
    APA Style
    
                                Niioka, T.,                                 Kagaya, H.,                                 Saito, M.,                                 Inoue, T.,                                 Numakura, K.,                                 Habuchi, T.,                                 Satoh, S.,                                 & Miura, M.        
        
        (2015). Capability of Utilizing CYP3A5 Polymorphisms to Predict Therapeutic Dosage of Tacrolimus at Early Stage  Post-Renal Transplantation. International Journal of Molecular Sciences, 16(1), 1840-1854.
        https://doi.org/10.3390/ijms16011840